跳至主要内容
临床试验/ISRCTN40292537
ISRCTN40292537已完成未知

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): an observational study using linked Scottish national data

Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)0 个研究点目标入组 5,400,000 人开始时间: 2020年11月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5,400,000

研究概览

简要总结

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32565483/ protocol published at: 2021 Preprint results in http://dx.doi.org/10.2139/ssrn.3789264 non-peer-reviewed results (added 23/03/2021) 2022 Results article in https://doi.org/10.1016/S0140-6736(21)00677-2 (added 26/05/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • All (anonymised) patient data will be collected

排除标准

  • Does not meet inclusion criteria

研究者

发起方
Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)

相似试验